_MG_4758

FAQ

Have questions about Cellda AB, our innovative cancer diagnostics, or how our technology works? Explore our frequently asked questions to find answers and gain a deeper understanding of our mission and solutions.

Common questions and answers

Here you can find the answers to the most common questions. Do you have additional questions? Contact us.

What is Cellda AB's primary focus?

Cellda AB specializes in next-generation algorithmic analysis in digital pathology, with a primary focus on improving prostate cancer diagnostics.

How does Cellda® Image Analysis Suite work?

Cellda® Image Analysis Suite utilizes advanced algorithms to analyze digital images of prostate biopsies, providing faster, more objective, and accurate cancer diagnoses

Can Cellda® Image Analysis Suite be integrated into existing pathology lab workflows?

Yes, Cellda® Image Analysis Suite seamlessly integrates into pathology lab workflows, from biopsy collection to sample scanning, making it a convenient tool for healthcare professionals.

What benefits does Cellda® Image Analysis Suite offer?

Cellda® Image Analysis Suite enhances diagnostics by reducing time, costs, and subjectivity. It improves patient care and contributes to better healthcare efficiency.

How can I learn more about Cellda AB's research and publications?

You can explore our library of publications on our website to gain insights into our research and innovations.

Are there investment opportunities with Cellda AB?

Yes, Cellda AB welcomes strategic investments from organizations and individuals who share our vision for advancing cancer diagnostics. Contact us for more information.

How can I get in touch with Cellda AB for additional questions or inquiries?

Feel free to contact us via our website, and our team will be happy to assist you with any additional questions or inquiries you may have.

Ready to Transform Cancer Diagnosis?

Join Us in the Future of Healthcare

Discover how Cellda AB is revolutionizing prostate cancer diagnostics. Join the future today.